Anti-MAP4K1/HPK1 antibody,Abcam,AB129319

Host

Goat

Reactivity

Human

Application

WB, IHC-P

Platform ID

BAB253500084

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-MAP4K1/HPK1 antibody
Cat. No.AB129319
HostGoat
IsotypeIgG
ReactivityHuman
ApplicationWB, IHC-P
ClonalityPolyclonal
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Human MAP4K1 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.3 Preservative: 0.02% Sodium azide Constituents: 99% Tris buffered saline, 0.5% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Serine/threonine-protein kinase, which plays a role in the response to environmental stress (PubMed : 24362026). Appears to act upstream of the JUN N-terminal pathway (PubMed : 8824585). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed : 26437443). May play a role in hematopoietic lineage decisions and growth regulation (PubMed : 24362026, PubMed : 8824585). Together with CLNK, it enhances CD3-triggered activation of T-cells and subsequent IL2 production (By similarity). See full target information MAP4K1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.